Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$584,005
+$166,656 QoQ
Shares Held
16,516
+10.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OMERS ADMINISTRATION Corp holds $15,680,712 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
12,641 | $7,495,860 | |
| 2 | ZTS |
Zoetis Inc.
|
29,535 | $3,491,332 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
226,310 | $794,348 | |
| 4 | VTRS |
Viatris Inc
|
50,088 | $676,688 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
13,100 | $630,765 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
4,615 | $607,980 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,214 | $585,642 | |
| 8 | ALKS |
Alkermes plc.
This page
|
16,516 | $584,005 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $584,005 | 16,516 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $417,349 | 14,916 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $885,000 | 29,500 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $1,620,621 | 57,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,395,390 | 57,900 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $958,278 | 35,400 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $249,660 | 9,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||